Personalized risk estimates of advanced neoplasia development in individuals with a family history of colorectal cancer
Familial Cancer · 14.05.2026 · 25 (2)
DOI: 10.1007/s10689-026-00565-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Familial Cancer, online erschienen am 14.05.2026. Verfasst von Marjolein J E Greuter und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit Amsterdam, C-371, Van der Boechorststraat 7, …. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Adenoma. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Organization for Health Research and Development (ZonMw).
Abstract (Originalsprache)
To optimize surveillance in individuals with a family history (FH) of colorectal cancer (CRC), knowledge on the incidence rate of non-advanced adenomas (nAAs) and their progression rate to advanced neoplasia (AN) is crucial. We jointly estimated personalized adenoma incidence and progression rates using a novel statistical approach. We used data of individuals with ≥ 1 first-degree relative with CRC who underwent ≥ 2 colonoscopies ( n = 876 individuals; n = 2384 colonoscopies). Interval-censored data on timing and yield (no adenomas/nAA/AN) of each colonoscopy were available. nAA incidence and progression time from nAA to AN were estimated using a Bayesian progressive three-state model. Over a median follow-up of 6 years (interquartile range 5–6), 60 (6.8%) individuals developed AN (2 CRC, 58 AA) while 246 (28.1%) developed a nAA. The 5-year risk of developing nAA from baseline was estimated to be 29% (95% Crl: 21–39%). This risk was significantly associated with age and FH type. Estimated risk of progressing to AN within 5 years since nAA onset was 29% (95% Crl: 21–39%), and was significantly associated with having advanced adenomas at baseline. This resulted in a 5-year risk of transitioning from ‘no adenomas’ to AN of 7% (95% Crl: 5–9%). We showed that only 7% of individuals develop AN (primarily AAs) within the current 5-year colonoscopy surveillance interval. Future studies should evaluate whether this relatively low risk justifies slight extension of the surveillance interval or the use of fecal testing to guide colonoscopy timing. Furthermore, surveillance intensity could potentially be tailored based on age and FH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit Amsterdam, C-371, Van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands. mj.greuter@amsterdamumc.nl.
- Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit Amsterdam, C-371, Van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands.
- Department of Gastroenterology and Hepatology, Medisch Spectrum Twente, Enschede, The Netherlands.
- Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Gastroenterology and Hepatology, Rijnstate Hospital, Arnhem, The Netherlands.
- Department of Pathology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
ORCID-Profile: Marjolein J E Greuter, Eddymurphy U Akwiwu, Tanya M Bisseling, Iris D Nagtegaal, Nicoline Hoogerbrugge, Veerle M H Coupé
Förderung
- Dutch Organization for Health Research and Development (ZonMw)
Zitieren
APA
Greuter, M. J. E., Akwiwu, E. U., Hennink, S. D., Bisseling, T. M., Spanier, M. B. W., German Consortium for Familial Intestinal Cancer, Nagtegaal, I. D., Canfell, K., Dekker, E., Klausch, T., Lansdorp-Vogelaar, I., van Leerdam, M. E., Hoogerbrugge, N., & Coupé, V. M. H. (2026). Personalized risk estimates of advanced neoplasia development in individuals with a family history of colorectal cancer. Familial Cancer, 25(2). https://doi.org/10.1007/s10689-026-00565-0
Vancouver
Greuter MJE, Akwiwu EU, Hennink SD, Bisseling TM, Spanier MBW, German Consortium for Familial Intestinal Cancer, et al. Personalized risk estimates of advanced neoplasia development in individuals with a family history of colorectal cancer. Familial Cancer. 2026;25(2). doi:10.1007/s10689-026-00565-0
BibTeX
@article{Greuter2026,
author = {Greuter, Marjolein J E and Akwiwu, Eddymurphy U and Hennink, Simone D and Bisseling, Tanya M and Spanier, Marcel B W and German Consortium for Familial Intestinal Cancer, German Consortium for Familial Intestinal Cancer and Nagtegaal, Iris D and Canfell, Karen and Dekker, Evelien and Klausch, Thomas and Lansdorp-Vogelaar, Iris and van Leerdam, Monique E and Hoogerbrugge, Nicoline and Coupé, Veerle M H},
title = {Personalized risk estimates of advanced neoplasia development in individuals with a family history of colorectal cancer},
journal = {Familial Cancer},
year = {2026},
volume = {25},
number = {2},
doi = {10.1007/s10689-026-00565-0}
}
EUVIMED